United Therapeutics (TETON-OLE) RIN-PF-302 - Clinical Trial

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease RIN-PF-302 TETON-OLE
Principal Investigator
Lake D. Morrison, MD
Pulmonologist
Protocol Number
IRB: PRO00118391
NCT: NCT04905693
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Support Duke Health research or honor a loved one with a tribute gift.
Giving to Duke Health